CROSS RISK Trademark
CROSS RISK is a USPTO trademark filed by SANOFI-AVENTIS. Status: Cancelled.
Trademark Facts
| Mark | CROSS RISK |
|---|---|
| Serial Number | 78040490 |
| Registration Number | 2695688 |
| Status | Cancelled |
| Filing Date | 2000-12-22 |
| Registration Date | 2003-03-11 |
| Mark Type | Word |
| Nice Classes | 005 (Pharmaceuticals), 016 (Paper Goods), 035 (Advertising & Business), 038 (Telecommunications), 041 (Education & Entertainment), 042 (Software & IT) |
| Owner | SANOFI-AVENTIS |
| Attorney of Record | Mark I. Peroff |
| Prosecution Events | 28 |
| Latest Event | C8.. on 2009-10-17 |
Goods & Services
Class 005: Pharmaceutical preparations for the prevention and treatment of cardiovascular diseases, disorders and conditions; Class 016: Printed matter, namely, brochures, postcards, magazines, newsletters and leaflets in the field of pharmaceuticals, pharmaceutical research and healthcare; Class 035: Arranging and conducting trade shows and exhibitions in the field of pharmaceuticals, pharmaceutical research and healthcare; dissemination of advertising matter; distribution of brochures, postcards, magazines, newsletters and leaflets; product demonstration and merchandising; production of audio and video commercials and infomercials; direct mail advertising; preparation of audio-visual and printed presentations and material for use in advertising; market research in the field of pharmaceuticals, pharmaceutical research and healthcare; Class 038: Providing multiple-user access to a global computer information network; Class 041: Educational services, namely, conducting and sponsoring conferences, discussion groups, seminars and lectures in the field of pharmaceuticals, pharmaceutical research and healthcare; conducting classes and providing public service and educational announcements by means of radio, newsletters, and brochures, all in the field of pharmaceuticals, pharmaceutical research and healthcare; Class 042: Computer services, namely, providing databases via the Internet in the field of pharmaceuticals, pharmaceutical research and healthcare